Changes in NK phenotype were most evident in AML, with significant declines in granzyme (Figure 4A), CD16 (Figure 4B), CD57 (Figure 4C), and NKG2D (Figure 4D). This evidence concerns the gene B3GAT1 and acute myeloid leukemia.